345 filings
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
8 Aug 23
Departure of Directors or Certain Officers
4:23pm
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
13 Jul 23
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
5:27pm
8-K
88avh15na5un
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
ns6190de88pt xf
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
5nivih4 98v6jvupu4
16 Jun 23
Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
5:22pm
8-K
bt9q6pde 0hz26a
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
d1div3lhcajz1ga
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
0sirv 74o6mp8t
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
u9my5m6skamvikm64ksn
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
624kq9 49
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
8-K
cib3yklnyhlvuqre
21 Mar 23
Navidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results
4:05pm
8-K
zso o558f
16 Mar 23
Departure of Directors or Certain Officers
4:31pm
8-K
8y6l8qufslof9n736nz
10 Jan 23
Entry into a Material Definitive Agreement
4:41pm
8-K
bbvi87dn8f7
12 Dec 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
r1nvqv7w3w
15 Nov 22
Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results
4:00pm
8-K
yt8 9vzz5yz1gp
30 Sep 22
Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders
8:45am
8-K
s3byh
15 Sep 22
Departure of Directors or Certain Officers
4:51pm